Excited about this @theisn.org initiative, especially under the leadership of @hswapnil.medsky.social as EIC. Nephrology needed this www.theisn.org/blog/2025/12...

Yes. This is a game changer. Beyond being able to replace AVS, it allows one to “see” the underlying pathological contributors to a large proportion of “idiopathic” hypertension. This is another piece of evidence that should make clinicians rethink the pathogenesis and treatment of hypertension

Ok, we have a winner. Thanks. bsky.app/profile/matt...

2025 @thelancet.com #CKD seminar out! Read it for latest evidence on how to manage what is projected to become a top 5 leading cause of death globally by 2050 (read it so in 25years’ time that does not happen…): www.sciencedirect.com/science/arti...

I think Aliza Thompson is an unsung hero in this story for spearheading the albuminuria acceptance at FDA journals.lww.com/cjasn/pages/... #NephJC

Sinead, current GN fellow. Exciting times in IgAN/nephrology in general. No COI. Mainly lurking tonight. #NephJC

Clinical Variability of ADPKD in Monozygotic Twins www.kireports.org/article/S246...

And paper 3 from @cervantes-lily1.bsky.social On adaptation of the Navigate Kidney intervention in @kireports.bsky.social www.kireports.org/article/S246... #KidneyWk

And the GBD analysis on CKD From @paddymark.bsky.social and colleagues www.thelancet.com/journals/lan... in @thelancet.com #KidneyWk

Trials coming out already! jamanetwork.com/journals/jam... Rituximab better than placebo in FRNS/SDNS Duh. #KidneyWk #NephSky

Another simultaneous publication from the afternoon session Albuminuria as an acceptable surrogate outcome (per our discussion earlier today) www.nature.com/articles/s41... in @naturemedicine.bsky.social @nature.com sadly paywalled #KidneyWk

ORIGIN phase 3 trial: In an interim analysis of a clinical trial, atacicept, a fusion protein that binds and inhibits two cytokines thought to be central to the pathophysiology of IgA nephropathy, significantly reduced proteinuria. nej.md/3JEq8QL @asnkidney.bsky.social | #KidneyWk

The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using equations that include both creatinine and cystatin C for more accurate GFR estimation and risk assessment in CKD. ja.ma/43QS5vy

I like to lump patients with type IV collagen variants into 4 main categories that can help predict risk of progression and recommended treatment. #KidneyWk

Highlights from my talk yesterday on Alport syndrome spectrum of disorders. (since no one posted it, I'll have to do it myself) Variants in type IV collagen cause a wide spectrum of disease. #KidneyWk 🧵

watch out - ORIGIN-3 and FINEONE likely simultaneous publications tomorrow morning! #KidneyWk

Fantastic Day 1 ✅ #KidneyWk @asnkidney.bsky.social

Idea for a Christmas BMJ paper: submit loads of Christmas BMJ papers, then do a survival analysis of time to rejection. Then submit the survival analysis as a Christmas BMJ paper the following year

Crescents at various stages of maturation (cellular, fibrocellular, fibrous):

I’m Sinead and I “have a faulty amygdala”. As per a neurologist I worked for.

There we are! Right alongside journalists and Pokemon fans! @hswapnil.bsky.social killing it!

“Patients who are diagnosed with ACE inhibitor-induced angioedema should be tested for hereditary angioedema types 1/2“ So far, not something that I have been doing … #whatilearnedtoday #nephsky #skyneph onlinelibrary.wiley.com/doi/10.1111/...

❄️🌬" Snow White Tales in Nephrology" ❄️ 💥Our latest article collects evidences from the published literature between skin whitening creams and glomerular diseases. 🌟 🩺 https://buff.ly/3CBzGIy

📢 Our systematic review published in BMC Nephrology examines the potential of continuous glucose monitoring (CGM) in improving glycemic control for patients with diabetes and the challenges of managing blood glucose levels in this unique population and highlights promising results from CGM use.

Still very cool to sit in grand rounds and see a #VisualAbstract after #VisualAbstract make it into the slide deck. Hard to underestimate how much good science AND good design helps dissemination. #medsky

Just landed here! Looks very good. Happy to meet so many known faces here.

#NephJC comment from EP specialist on the significance of CSCA See @christosargyrop.bsky.social even asystolic pauses are seemingly common 😳

#NephJC is about the community, it wouldn't be the same, or even live for so long without any of you (remember? we celebrated 10 years 🥳) We want to move it forward. If you want to (re)find your people see the #NephSky starter packs @hswapnil.bsky.social put together bsky.app/profile/hsw...

Sinead Stoneman, long time #NephJC lover. Glad and proud I can join the chat tonight, though I’ll be mainly lurking. No COI.

Also #BlueSky has crossed 20 million users #AskRenal is up & running bsky.app/profile/did:... (Thanks @drnikhilshah.bsky.social) The @theisn.org got a custom domain 🙌🏽 @kidneyboy.bsky.social proves 🦋>> 🐦 #NephSky update

So @kidneyboy.bsky.social has 15 times more followers on Xitter (along with algorithm boosting blue check) versus a ‘BlueSky Elder’ coveted label here Same post comparison below It’s a #BlueSky blowout #NephSky

@nephjc.bsky.social Check out the lovely VA for tonight’s discussion from Madiha Aziz. #NephJC

Two recent reviews of #ANCA vasculitis with wonderful graphics, and for the first time I think, #PR3 🔹 and #MPO 🔸 phenotypes considered in parallel but SEPARATELY! A new era with individualized treatment is coming for sure! 🔹 pubmed.ncbi.nlm.nih.gov/38574742/ 🔸 pubmed.ncbi.nlm.nih.gov/38574743/

Dear #AskRenal friends - Finally, I have a feed up and running! Still trying to get the repost and like feature working. Feed: bsky.app/profile/did:... Questions - DM me - @drnikhilshah.bsky.social #NephSky #MedSky @nephjc.bsky.social l @hswapnil.bsky.social l @kidneyboy.bsky.social

when you see the Juurlink name on a paper - worry about which drug is going to get slaughtered eg Spironolactone pubmed.ncbi.nlm.nih.gov/15295047/ so imagine our concern when we saw this case report: pubmed.ncbi.nlm.nih.gov/32744865/ my two favorites: flozin + statin = rhabdomyolysis?😱 1/

make sure to check out all the 4 nephrology starter packs! 4th pack: go.bsky.app/YeuH82 3rd Nephrology pack: go.bsky.app/2yLiYN4 Second pack go.bsky.app/N27Kzri First pack: go.bsky.app/H4td28C (just added you to pack 4) #NephSky

Moving from Twitter? Looking for #vasculits #glomerulonephritis lovers? Starter pack (work in progress): go.bsky.app/HFADD3c. Reply or DM to be added in the list!

Interesting case of ANCA GN apparently triggered by COVID infection. Also showed concurrent membranous features with MPO+(IHC below) IgG (IF below) deposits as has been described: www.sciencedirect.com/science/arti.... #renalpath #nephrology #pathsky

All in! go.bsky.app/2yLiYN4 Now get the ERA, UKKA and the journals on board too!

@silvishah.bsky.social Huge congratulations on your AHA award!! Way to go! Love the cardiorenal crossover ❤️ #nephsky Photos from other platform courtesy of Martha Gulati @drmarthagulati.bsky.social

We need a pubpeer for science journalism and press releases.

The Chronicles of Chronotherapy in hypertension, on MARKUS @ Home with @rickyturgeon.bsky.social Scott Garrison And Isla Mackenzie #HTSky www.youtube.com/watch?v=mqkT...

Good morning! Nov 15 AM update: The 3rd Nephrology pack is well known its way: go.bsky.app/2yLiYN4 Second pack go.bsky.app/N27Kzri First pack: go.bsky.app/H4td28C Hypertension Nerds go.bsky.app/KBLojr Kidney/HT Journals go.bsky.app/2BG7wKr Please reply or DM me to be added!

Thrilled to find the Nephrology community here #nephsky Looking forward to reconnecting with my fellow nephrons and social media connoisseurs! @toates.bsky.social @hswapnil.bsky.social @kidneyboy.bsky.social @nephrosparks.bsky.social @sstoneman.bsky.social

This study is going to be the topic of #NephJC ’s first journal club on Bluesky. Next Tuesday 9pm EST.

Hey #NephSky peeps The Nephrology Starter pack has 150 (which is the limit) These are the last few additions bsky.app/profile/hswa... If you are in the kidney/renal/nephrology space and not on this list, let me know here! Will get started on pack #2 accordingly!

In clinical research, you will often receive feedback on study design, stats, and/or data analysis from an editor or reviewer that is simply wrong. Here is a list of common "statistical myths" and references you can use to push back. discourse.datamethods.org/t/reference-...

‘T$&@& is cholera. His hate, his lies, it’s an infection that’s in the drinking water now’ Tech bros, social media and politics Good read from @carolecadwalla.bsky.social www.theguardian.com/commentisfre...

Smiling glomerulus to brighten your day. #pathology #renalpath #nephropathy #nephropath

Our last #NephJC was on #flozination. We discussed the long-term effects of empagliflozin on CKD & revisited the EMPA-KIDNEY study #NephSky 👉 See the summary blog: www.nephjc.com/news/empa-lo...